KLOW

KLOW is a research-grade combination peptide formulation that consolidates four extensively studied compounds into a single vial — BPC-157, TB-500, KPV, and GHK-Cu. Each component targets complementary biological pathways, providing researchers with a unified reagent for investigating multi-pathway tissue-protection, repair, and remodelling mechanisms simultaneously. The acronym reflects the four constituents (KPV, LKK[T]ETQ fragment of TB-500, OCTA of BPC, and GHK-Cu copper tripeptide).

Available in 80mg vials (combined formulation). Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

• Multi-pathway tissue repair and wound healing modulation studies
• Anti-inflammatory signalling research via KPV and BPC-157 mechanisms
• Musculoskeletal regeneration through TB-500 actin-binding pathways
• Collagen synthesis and skin matrix remodelling via GHK-Cu copper signalling
• Synergistic vs single-compound comparative research models
• Multi-target tissue-protection and regenerative biology studies

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99% (HPLC verified)
• Storage: −20°C, protected from light and moisture
• Available size: 80mg combined
• Origin: UK warehouse, same day dispatch